启迪药业：控股股东所持5860.7万股股票拍卖成交 或致公司控制权变更

Core Viewpoint - The controlling shareholder of Qidi Pharmaceutical, Qidi Technology Service Co., Ltd., has successfully auctioned 58.607 million shares, which may lead to a change in the company's control [1] Group 1: Share Auction Details - Qidi Pharmaceutical announced that 58.607 million shares held by its controlling shareholder were auctioned on JD.com’s judicial auction platform [1] - The successful bidder, Hunan Sailoxian Management Consulting Partnership, acquired the shares for a total price of 1.007 billion yuan, averaging 17.19 yuan per share [1] - This auction price is significantly higher than the company's latest closing price of 13.86 yuan per share [1] Group 2: Potential Control Change - If the judicial auction is completed and the share transfer is executed, Hunan Sailoxian will hold 58.607 million shares, representing 24.47% of the company's total share capital [1] - This acquisition may result in Hunan Sailoxian obtaining control over Qidi Pharmaceutical [1]